Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-acetyl-D-mannosamine monohydrate

EU orphan designation number: EU/3/16/1635   
Active ingredient: N-acetyl-D-mannosamine monohydrate
Indication: Treatment of GNE myopathy
Sponsor: Escala Therapeutics Ltd
c/o Howard Kennedy LLP, No 1 London Bridge, London SE1 9BG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/03/2016 Orphan designation EMA/OD/228/15 (2016)1873 of 21/03/2016